SCHEMBL18393435

SCHEMBL18393435

CC(C)(C)N1CCC(n2cc(I)c3c(N)ncnc32)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTOR P42345 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ ADK P55263 11/20 0.46
▸ SRC P12931 5/20 0.45
▸ EGFR P00533 2/20 0.45
▸ ABL1 P00519 2/20 0.42
▸ FGFR1 P11362 2/20 0.42
▸ DAPK3 O43293 1/20 0.42
▸ MAP4K4 O95819 1/20 0.42
▸ PAK4 O96013 1/20 0.42
▸ LCK P06239 1/20 0.42
▸ FYN P06241 1/20 0.42
▸ CSF1R P07333 1/20 0.42
▸ RET P07949 1/20 0.42
▸ IGF1R P08069 1/20 0.42
▸ PRKACA P17612 1/20 0.42
▸ FLT1 P17948 1/20 0.42
▸ LTK P29376 1/20 0.42
▸ KDR P35968 1/20 0.42
▸ MAP2K2 P36507 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18393434 1.00 MTOR (0.47) MTORRAB9AADKSRCEGFR
SCHEMBL16236916 0.84 MTOR (0.50) MTORRAB9AADKSRCEGFR
SCHEMBL19743546 0.81 MTOR (0.52) MTORRAB9AADKSRCEGFR
SCHEMBL16237288 0.80 SRC (0.59) MTORRAB9AADKSRCEGFR
SCHEMBL30120727 0.80 ABL1 (0.48) MTORRAB9AADKSRCEGFR
SCHEMBL16236082 0.80 ABL1 (0.48) MTORRAB9AADKSRCEGFR
SCHEMBL20981824 0.79 SRC (0.51) MTORRAB9AADKSRCEGFR
SCHEMBL13857873 0.79 ADK (0.45) MTORRAB9AADKSRCEGFR
SCHEMBL29388723 0.79 ADK (0.47) MTORRAB9AADKSRCEGFR
SCHEMBL19743265 0.79 SRC (0.52) MTORRAB9AADKSRCEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3120852-A1 PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR IMMUNE DISEASES Taiho Pharmaceutical Co., Ltd. (JP) 2017-01-25 — — EP disclosed
Send feedback